Notice of Special Interest (NOSI): Telehealth in Cancer Care
This funding record is inactive. Please see the program website or contact the program sponsor to determine if this program is currently accepting applications or will open again in the future.
Gurvaneet Randhawa, MD, MPH
240.276.6940
Gurvaneet.Randhawa@nih.gov
Kelly Blake, ScD
240.281.5934
Kelly.Blake@nih.gov
The National Cancer Institute published this Notice of Special Interest (NOSI) for research on the use of telehealth in cancer-related care, with a focus on populations that experience inequities in access to care and have worse cancer outcomes compared to the general population.
Examples of research topics include, but are not limited to:
- The effectiveness of telehealth for primary and secondary cancer prevention such as counseling for tobacco, alcohol, physical activity, diet, HPV vaccination, and mental health
- The effectiveness of telehealth interventions aiming to increase cancer screening rates, improve the accuracy and timeliness of cancer diagnoses, and initiate appropriate cancer treatment
- The effectiveness of telehealth in improving treatment and management of cancer and/or the provision of palliative care
- The use of telehealth to support cancer survivors, including surveillance for adverse effects of cancer treatments, recurrence of cancer, and treatment of co-morbidities
- The impact of telehealth on patient, family, and caregiver experiences with care and quality of life in the context of cancer care
- The quality and effectiveness of telehealth interactions in promoting patient-centered communication
- Understand the tasks, and the time and cognitive burden of performing the tasks, imposed by the telehealth interactions on patients and their caregivers
- The effectiveness of telehealth in improving communication and coordination of oncology care, including communication and coordination between oncology care and primary care providers
- Understand the clinical workflow and the cognitive and other burdens imposed by current clinical information technology systems on providers in their telehealth-related interactions
- Understand how organizational policies, clinical team interactions, and the configuration of IT systems influence the clinical workflow and delivery of telehealth
- Examine the cost effectiveness of telehealth in cancer-related care
National Cancer Institute encourages research on populations that experience inequities in access to care, have limited access to broadband and digital technologies, have low health and/or digital literacy, and have worse cancer outcomes compared to the general population, especially those accessing care in community oncology practices, including those in rural areas or those serving under-served populations.
Eligible applicants include:
- Higher education institutions
- Public/state controlled institutions
- Private institutions
- Nonprofit organizations
- With 501(c)(3) status
- Without 501(c)(3) status
- Native American tribal organizations
- Faith-based or community-based organizations
- Regional organizations
- Governments
- State
- County
- City or township
- Special districts
- Federally recognized Indian/Native American tribal governments
- Indian/Native American tribal governments (other than federally recognized)
- Eligible agencies of the federal government
- U.S. territory or possession
- Other
- Independent school districts
- Public housing authorities
- Indian housing authorities
- Small businesses
- For-profit organizations
Award amounts are determined by the guidelines of the specific related opportunity.
This is a NOSI that is attached to related NIH announcements:
- PAR-21-190 - Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
- PAR-21-035 - Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- PAR-19-348 - Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
- PAR-19-350 - Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
Applicants should submit proposals to the appropriate related announcement and indicate that it is a response to the NOSI.
Investigators planning to submit an application are strongly encouraged to contact and discuss their proposed research with program staff well in advance of the anticipated submission date to better determine appropriateness and interest.
The NOSI expires on March 8, 2024.
Related Content
Organizations (2)
- National Institutes of Health, view details
- National Cancer Institute, view details
For complete information about funding programs, including your
application status, please contact funders directly. Summaries are provided
for your convenience only. RHIhub does not take part in application processes
or monitor application status.